Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 28 studies | 35% ± 15% | |
| B cell | 16 studies | 26% ± 10% | |
| macrophage | 15 studies | 38% ± 19% | |
| astrocyte | 12 studies | 37% ± 17% | |
| microglial cell | 12 studies | 37% ± 14% | |
| glutamatergic neuron | 11 studies | 40% ± 26% | |
| oligodendrocyte precursor cell | 11 studies | 38% ± 17% | |
| oligodendrocyte | 11 studies | 35% ± 14% | |
| GABAergic neuron | 10 studies | 45% ± 23% | |
| pericyte | 10 studies | 33% ± 14% | |
| fibroblast | 10 studies | 27% ± 11% | |
| epithelial cell | 9 studies | 36% ± 18% | |
| adipocyte | 9 studies | 30% ± 9% | |
| myeloid cell | 8 studies | 31% ± 9% | |
| dendritic cell | 8 studies | 35% ± 10% | |
| type I pneumocyte | 8 studies | 31% ± 13% | |
| smooth muscle cell | 7 studies | 29% ± 10% | |
| endothelial cell of lymphatic vessel | 7 studies | 34% ± 13% | |
| neuron | 6 studies | 40% ± 17% | |
| interneuron | 6 studies | 51% ± 23% | |
| basal cell | 6 studies | 32% ± 19% | |
| ciliated cell | 6 studies | 26% ± 9% | |
| type II pneumocyte | 6 studies | 29% ± 9% | |
| capillary endothelial cell | 5 studies | 29% ± 12% | |
| cardiac muscle cell | 5 studies | 34% ± 9% | |
| retinal cone cell | 5 studies | 26% ± 10% | |
| monocyte | 5 studies | 36% ± 9% | |
| goblet cell | 5 studies | 29% ± 22% | |
| club cell | 5 studies | 32% ± 12% | |
| CD4-positive, alpha-beta T cell | 4 studies | 17% ± 1% | |
| classical monocyte | 4 studies | 25% ± 8% | |
| effector memory CD8-positive, alpha-beta T cell | 4 studies | 18% ± 1% | |
| non-classical monocyte | 4 studies | 29% ± 12% | |
| endothelial cell of artery | 4 studies | 19% ± 3% | |
| granule cell | 4 studies | 26% ± 8% | |
| mast cell | 4 studies | 23% ± 9% | |
| mesothelial cell | 4 studies | 28% ± 9% | |
| lymphocyte | 4 studies | 28% ± 10% | |
| retinal rod cell | 4 studies | 27% ± 7% | |
| T cell | 4 studies | 23% ± 4% | |
| natural killer cell | 4 studies | 19% ± 2% | |
| abnormal cell | 4 studies | 26% ± 15% | |
| respiratory goblet cell | 4 studies | 35% ± 12% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 2% | |
| GABAergic interneuron | 3 studies | 42% ± 9% | |
| glial cell | 3 studies | 29% ± 10% | |
| naive B cell | 3 studies | 18% ± 4% | |
| plasma cell | 3 studies | 33% ± 6% | |
| mononuclear phagocyte | 3 studies | 31% ± 9% | |
| vein endothelial cell | 3 studies | 43% ± 27% | |
| Mueller cell | 3 studies | 26% ± 7% | |
| amacrine cell | 3 studies | 25% ± 10% | |
| endothelial cell of vascular tree | 3 studies | 43% ± 23% | |
| hepatocyte | 3 studies | 38% ± 12% | |
| ependymal cell | 3 studies | 28% ± 13% | |
| alveolar macrophage | 3 studies | 43% ± 13% | |
| transit amplifying cell | 3 studies | 39% ± 29% | |
| brush cell | 3 studies | 27% ± 9% | |
| plasmacytoid dendritic cell | 3 studies | 19% ± 4% | |
| renal alpha-intercalated cell | 3 studies | 26% ± 9% | |
| renal principal cell | 3 studies | 21% ± 6% | |
| mucus secreting cell | 3 studies | 30% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3917.55 | 1445 / 1445 | 100% | 24.72 | 183 / 183 |
| intestine | 100% | 4458.24 | 966 / 966 | 100% | 20.90 | 527 / 527 |
| prostate | 100% | 4681.80 | 245 / 245 | 100% | 39.53 | 502 / 502 |
| stomach | 100% | 3823.19 | 359 / 359 | 100% | 20.17 | 286 / 286 |
| thymus | 100% | 5764.36 | 653 / 653 | 100% | 24.31 | 605 / 605 |
| lung | 100% | 4562.24 | 578 / 578 | 100% | 23.80 | 1154 / 1155 |
| kidney | 100% | 4441.28 | 89 / 89 | 100% | 23.65 | 899 / 901 |
| breast | 100% | 4229.20 | 459 / 459 | 100% | 27.81 | 1114 / 1118 |
| brain | 100% | 2968.69 | 2632 / 2642 | 100% | 26.49 | 705 / 705 |
| bladder | 100% | 4070.62 | 21 / 21 | 100% | 17.63 | 502 / 504 |
| pancreas | 100% | 2761.00 | 328 / 328 | 99% | 19.54 | 177 / 178 |
| uterus | 100% | 3937.92 | 170 / 170 | 99% | 17.00 | 456 / 459 |
| ovary | 100% | 3415.83 | 180 / 180 | 98% | 12.53 | 422 / 430 |
| adrenal gland | 100% | 7528.81 | 258 / 258 | 98% | 21.40 | 225 / 230 |
| liver | 100% | 2283.22 | 226 / 226 | 95% | 11.62 | 387 / 406 |
| skin | 100% | 2974.60 | 1808 / 1809 | 92% | 11.99 | 433 / 472 |
| adipose | 100% | 4346.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3792.30 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 14.86 | 29 / 29 |
| muscle | 100% | 10932.98 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4623.19 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 14.89 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.69 | 1 / 1 |
| heart | 99% | 3927.16 | 851 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 85% | 2066.46 | 792 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 78% | 9.03 | 62 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006091 | Biological process | generation of precursor metabolites and energy |
| GO_0005977 | Biological process | glycogen metabolic process |
| GO_0005964 | Cellular component | phosphorylase kinase complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005516 | Molecular function | calmodulin binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PHKB |
| Protein name | Phosphorylase kinase regulatory subunit beta Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta) Phosphorylase b kinase regulatory subunit |
| Synonyms | |
| Description | FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The beta chain acts as a regulatory unit and modulates the activity of the holoenzyme in response to phosphorylation. FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. . FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. . FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. . FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. . FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. . FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. . FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. . FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. . |
| Accessions | I3L3F2 ENST00000564873.1 Q6LAJ4 ENST00000696809.1 ENST00000566275.2 I3L213 A0A8V8TNH3 Q93100 A0A8Q3WM21 A0A0G2JLB9 ENST00000566037.6 ENST00000699276.1 ENST00000564711.2 ENST00000563376.5 ENST00000323584.10 [Q93100-1] I3NHZ9 ENST00000566044.5 [Q93100-4] ENST00000570047.2 H3BQ89 I3L1N3 I3L0Z1 H3BV13 ENST00000567200.1 ENST00000568439.1 ENST00000299167.12 [Q93100-3] |